Press release content from Globe Newswire. The AP news staff was not involved in its creation.
An Alternative Nationwide Health Information Network Has Launched to Scale and Solve National .
VelaturaFebruary 8, 2021 GMT
Grand Rapids, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) The United States QHIN (USQHIN) has launched as a wholly owned subsidiary of Velatura Public Benefit Corporation, which will use data exchange to scale and solve national interoperability challenges.
Historically, national data exchange has been limited by the challenges of exchanging integrated, rationalized data between disparate networks. USQHIN aims to solve this challenge by closing the gap between effective local or regional exchange and national exchange and by emphasizing collaboration and honoring existing network relationships to benefit all participants. USQHIN aligns with the currently understood vision and the federal regulatory guidelines for a national interoperability framework set forth in t
MedCity News
Bristol Myers lymphoma therapy acquired in Celgene deal wins FDA nod
After some setbacks and delays, the FDA approved Bristol Myers Squibb’s Breyanzi for certain lymphomas. It’s the fourth CAR T treatment to win the regulatory nod and the first under a new regenerative medicine designation.
Shares1
A Bristol Myers Squibb cancer immunotherapy that the pharmaceutical giant obtained via its Celgene acquisition was awarded FDA approval Friday, adding one more of this type of personalized medicine as a treatment option for certain forms of lymphoma.
The FDA approved the therapy, lisocabtagene maraleucel, as a treatment for adults who have certain types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL), whose cancer has not responded to or has relapsed after at least two other types of treatment. New York-based BMS will market the drug under the name Breyanzi.
Advertisement
HHS Finalizes Highly Anticipated Final Rule Amending Anti-Kickback Statute and Stark Law Regulations, Part V: Cybersecurity Technology and Electronic Health Records Friday, February 5, 2021
In this fifth installment of our blog series covering the changes, we dive into (i) the new AKS safe harbor and Stark Law exception for cybersecurity technology and related services, and (ii) the significant changes to the existing safe harbor and exception for electronic health records (EHR) technology.
Cybersecurity Technology and Related Services
In the face of mounting concerns about the financial losses and risks to patients caused by cyberattacks against hospitals and other health care providers, the agencies finalized a new safe harbor and a new exception for donations of cybersecurity technology and services. The health care industry – particularly hospitals – should welcome this new flexibility to donate cybersecurity technology and services to physic
February 4, 2021
By Deborah Borfitz
February 4, 2021 | A computer scientist at The Ohio State University (OSU) recently demonstrated the potential of artificial intelligence to crunch real-world data and emulate randomized clinical trials, speeding the pace of drug repurposing. The initial use case was focused on preventing heart failure and stroke in patients with coronary artery disease, but the model could be applied to any disease with a definable outcome, says Ping Zhang, who leads the Artificial Intelligence in Medicine Lab at OSU.
Zhang is senior author of a recently published study in
Nature Machine Intelligence (DOI: 10.1038/s42256-020-00276-w) where a deep learning algorithm ingested insurance claims on nearly 1.2 million deidentified patients to identify existing medications with a heretofore unknown therapeutic effect on coronary artery disease (CAD; e.g., diabetes drug metformin and antidepressant escitalopram, both of which were already being tested
U S GAO - Federal Research Grants: OMB Should Take Steps to Establish the Research Policy Board gao.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gao.gov Daily Mail and Mail on Sunday newspapers.